M. Morris-Downes

884 total citations
19 papers, 553 citations indexed

About

M. Morris-Downes is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, M. Morris-Downes has authored 19 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Immunology. Recurrent topics in M. Morris-Downes's work include Mosquito-borne diseases and control (5 papers), Viral Infections and Vectors (4 papers) and Multiple Sclerosis Research Studies (3 papers). M. Morris-Downes is often cited by papers focused on Mosquito-borne diseases and control (5 papers), Viral Infections and Vectors (4 papers) and Multiple Sclerosis Research Studies (3 papers). M. Morris-Downes collaborates with scholars based in Ireland, United Kingdom and Netherlands. M. Morris-Downes's co-authors include B. J. Sheahan, Sandra Amor, Gerald J. Atkins, Gregory J. Atkins, L. S. Harbige, D. C. Dumonde, Lorna Layward, Fidelma Fitzpatrick, David Baker and E.G. Smyth and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Vaccine and Molecular Therapy.

In The Last Decade

M. Morris-Downes

19 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Morris-Downes Ireland 15 162 156 115 114 106 19 553
D Piskorska Poland 10 250 1.5× 78 0.5× 120 1.0× 50 0.4× 58 0.5× 22 703
Kwang–Kyu Kim South Korea 5 204 1.3× 203 1.3× 175 1.5× 232 2.0× 293 2.8× 7 741
Hye‐Ran Cha South Korea 16 415 2.6× 97 0.6× 195 1.7× 130 1.1× 120 1.1× 28 822
Annie Mackellar United Kingdom 8 385 2.4× 124 0.8× 254 2.2× 140 1.2× 183 1.7× 10 881
Dong-Min Shin South Korea 7 274 1.7× 270 1.7× 189 1.6× 91 0.8× 372 3.5× 7 770
T Nurmi Finland 13 135 0.8× 73 0.5× 87 0.8× 58 0.5× 82 0.8× 26 516
Annalisa Lembo United States 12 439 2.7× 175 1.1× 308 2.7× 22 0.2× 184 1.7× 16 1.0k
Farhad Rezaei Iran 14 144 0.9× 203 1.3× 195 1.7× 35 0.3× 219 2.1× 58 677
Michael Lotz Germany 9 460 2.8× 93 0.6× 415 3.6× 27 0.2× 95 0.9× 9 1.0k

Countries citing papers authored by M. Morris-Downes

Since Specialization
Citations

This map shows the geographic impact of M. Morris-Downes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Morris-Downes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Morris-Downes more than expected).

Fields of papers citing papers by M. Morris-Downes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Morris-Downes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Morris-Downes. The network helps show where M. Morris-Downes may publish in the future.

Co-authorship network of co-authors of M. Morris-Downes

This figure shows the co-authorship network connecting the top 25 collaborators of M. Morris-Downes. A scholar is included among the top collaborators of M. Morris-Downes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Morris-Downes. M. Morris-Downes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Keane, Eimear, et al.. (2020). COVID-19 in the Mid-West - The response from the Department of Public Health, HSE Mid-West between January and September 2020. 1 indexed citations
2.
Morris, Dearbháile, Fiona Boyle, Carol Morris, et al.. (2012). Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. Journal of Antimicrobial Chemotherapy. 67(10). 2367–2372. 26 indexed citations
3.
O’Gorman, Joanne, M. Morris-Downes, Rachel Crowley, et al.. (2011). A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. Journal of Hospital Infection. 79(3). 218–221. 33 indexed citations
4.
Talento, Alida Fe, M. Morris-Downes, Tessy Thomas, et al.. (2011). Implementing peripheral vascular catheter care bundle in a tertiary care hospital: No room for complacency?. Lenus, The Irish Health Repository (Dr Steevens Hospital Library). 4 indexed citations
5.
Burns, Karen, M. Morris-Downes, Warren N. Fawley, et al.. (2010). Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland. Journal of Hospital Infection. 75(4). 287–291. 25 indexed citations
6.
McHugh, Seamus, Mark Corrigan, Borislav D. Dimitrov, et al.. (2010). Role of Patient Awareness in Prevention of Peripheral Vascular Catheter-Related Bloodstream Infection. Infection Control and Hospital Epidemiology. 32(1). 95–96. 22 indexed citations
7.
Morris-Downes, M., E.G. Smyth, Fidelma Fitzpatrick, et al.. (2010). Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible. Journal of Hospital Infection. 75(3). 228–233. 14 indexed citations
8.
O’Neill, Eoghan, et al.. (2009). Combined audit of hospital antibiotic use and a prevalence survey of healthcare-associated infection. Clinical Microbiology and Infection. 16(5). 513–515. 8 indexed citations
9.
Smith, Paul A., M. Morris-Downes, Nicole Heijmans, et al.. (2005). Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Journal of Neuroimmunology. 164(1-2). 76–84. 24 indexed citations
10.
Heijmans, Nicole, Paul A. Smith, M. Morris-Downes, et al.. (2005). Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice. Journal of Neuroimmunology. 167(1-2). 23–33. 6 indexed citations
11.
12.
13.
Morris-Downes, M.. (2002). Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. Journal of Neuroimmunology. 125(1-2). 114–124. 71 indexed citations
14.
Morris-Downes, M., K. V. Phenix, Joan A. Smyth, et al.. (2001). Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems. Vaccine. 19(15-16). 1978–1988. 45 indexed citations
15.
Morris-Downes, M., B. J. Sheahan, Marina N. Fleeton, et al.. (2001). A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model. Vaccine. 19(28-29). 3877–3884. 22 indexed citations
16.
Atkins, Gerald J., Stephen McQuaid, M. Morris-Downes, et al.. (2000). Transient virus infection and multiple sclerosis. Reviews in Medical Virology. 10(5). 291–303. 28 indexed citations
17.
Morris-Downes, M., et al.. (2000). A role for α4-integrin in the pathology following Semliki Forest virus infection. Journal of Neuroimmunology. 106(1-2). 60–68. 22 indexed citations
18.
Morris-Downes, M., et al.. (2000). Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Therapy. 7(17). 1477–1482. 59 indexed citations
19.
Harbige, L. S., Lorna Layward, M. Morris-Downes, D. C. Dumonde, & Sandra Amor. (2000). The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-β1) up-regulation and increased prostaglandin E2 (PGE2) production. Clinical & Experimental Immunology. 122(3). 445–452. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Piskorska Breakdown of academic impact, for papers by Kwang–Kyu Kim Breakdown of academic impact, for papers by Hye‐Ran Cha Breakdown of academic impact, for papers by Annie Mackellar Breakdown of academic impact, for papers by Dong-Min Shin Breakdown of academic impact, for papers by T Nurmi Breakdown of academic impact, for papers by Annalisa Lembo Breakdown of academic impact, for papers by Farhad Rezaei Breakdown of academic impact, for papers by Michael Lotz
Rankless by CCL
2026